Grace Zhao

Boston University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index3.0kcitations66works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(28), Lung Cancer Treatments and Mutations(9), RNA modifications and cancer(8), Molecular Biology Techniques and Applications(8), Epigenetics and DNA Methylation(6)

Publications60 total

Tryptophan metabolism reprogramming potentially contributes to the prothrombotic milieu in mice and humans with SARS-CoV-2
Blood Vessels Thrombosis & Hemostasis·2026Open Access
Analytical Performance of Agilent Avida Duo with Custom Multiomic Reference Standards
The Journal of Liquid Biopsy·2025Open Access
Abstract 5882: A novel NGS-based assay in kit format for tumor-independent cancer monitoring, and evaluation of patient treatment response using cfDNA genomic alteration and methylation duo analysis
Cancer Research·2025
Abstract 5900: Tumor-independent cfDNA methylation analysis for cancer monitoring during total neoadjuvant treatment in rectal cancer patients
Cancer Research·2025
Abstract 7191: Targeted genomic and epigenomic dual analysis of the same region for an entire single gene
Cancer Research·2025
Abstract 4070: Demonstrating analytical performance of Agilent Avida Duo utilizing novel multiomic reference standards
Cancer Research·2025
Cell-free DNA: plays an essential role in early diagnosis and immunotherapy of pancreatic cancer
Frontiers in Immunology·2025· 2 citedOpen Access
OpenAI o1 System Card
arXiv (Cornell University)·2024· 32 citedOpen Access
Fructose Consumption in Pregnancy and Associations with Maternal and Offspring Hepatic and Whole-Body Adiposity in Rodents: A Scoping Review
Current Developments in Nutrition·2024· 1 citedOpen Access
Fructose consumption in pregnancy and associations with maternal and offspring hepatic and whole-body adiposity: a scoping review
2024Open Access
Abstract 2291: Bravo automation of Agilent Avida targeted enrichment for high-throughput detection of genomic alteration and DNA methylation
Cancer Research·2024
1346 mTFF2-MSA (mTNX-1700) suppresses tumor growth in an Anti-PD-1 treated Pan02 syngeneic pancreatic cancer model by targeting MDSCs in C57BL/6 Mice
Regular and Young Investigator Award Abstracts·2023· 1 citedOpen Access
1345 mTFF2-MSA (mTNX-1700) suppresses tumor growth and increases survival in anti-PD-1 treated CT26.wt subcutaneous and CT26-Luciferase orthotopic syngeneic colorectal cancer models by targeting MDSCs
Regular and Young Investigator Award Abstracts·2023· 1 citedOpen Access
S1802 Duodenal Neuroendocrine Tumors: A 20-Year Clinico-Pathological Appraisal at a Large Safety Net Hospital
The American Journal of Gastroenterology·2023
S172 Overall Survival and Clinical-pathological Features of Rectal Neuroendocrine Tumors at a Large Safety-Net Hospital
The American Journal of Gastroenterology·2023
Abstract 259: Fully automated targeted sequencing sample prep on open platform liquid handlers
Cancer Research·2023· 1 cited
Abstract 788: Novel multiplex methylation-specific qPCR strategy for early CRC detection
Cancer Research·2023
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Cancer Cell·2022· 184 citedOpen Access
A novel NGS kit solution for multi-cancer early detection using circulating cell free DNA based methylation analysis.
Journal of Clinical Oncology·2022· 2 cited
Pandemic Response Requires Research Samples: A U.S. Safety-Net Hospital's Experience and Call for National Action
Annals of Internal Medicine·2021· 4 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Shengrong Lin(20), Li Weng(6), Jennifer L Raymond(5), Kang Ying(5), Heng Wang(5), Paul C. Tang(5), Xiaozheng Kang(4), Flora Jung(4), Jiatao Lou(4), Yun Bao(4), Hongyan Wang(4), Jing Ren(3), Alina Isakova(3), Drew Friedmann(3), Jiawei Zeng(3), Sophie M. Grutzner(3), Albert Pun(3), Sai Saroja Kolluru(3), Ruiyu Wang(3), Rui Lin(3)